/TOI
TOI Stock - The Oncology Institute, Inc.
Healthcare|Medical - Care FacilitiesNASDAQ
$3.71-3.77%
$0.14 (-3.77%) • Jan 13
84
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.76
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+35.0%upside
Target: $5.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TOI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.67 – $3.74
TARGET (TP)$5.00
STOP LOSS$3.41
RISK/REWARD1:4.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.18
52W High$4.88
52W Low$0.29
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $393.41M | $324.24M | $252.48M | $203.00M | $187.51M |
| Gross Profit | $54.00M | $59.57M | $52.09M | $40.85M | $36.88M |
| Gross Margin | 13.7% | 18.4% | 20.6% | 20.1% | 19.7% |
| Operating Income | $-60,118,000 | $-77,018,000 | $-81,951,000 | $-45,858,000 | $-8,195,903 |
| Net Income | $-64,663,000 | $-83,068,000 | $152,000 | $-10,927,000 | $-14,321,235 |
| Net Margin | -16.4% | -25.6% | 0.1% | -5.4% | -7.6% |
| EPS | $-0.71 | $-0.92 | $0.00 | $-0.16 | $-0.24 |
Company Overview
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
7 Bullish0 Neutral/Bearish
Price Targets
$7
Average Target
↑ 75.4% Upside
Now
$3
Low
$7
Average
$10
High
Based on 7 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 25th 2025 | Needham | Initiation | Buy | $5 |
| July 23rd 2025 | Noble Capital Markets | Initiation | Outperform | $8 |
| July 16th 2025 | B. Riley Securities | Initiation | Buy | $6 |
| May 15th 2025 | BTIG Research | Initiation | Buy | $7 |
| February 26th 2024 | Jefferies | Resumed | Buy | $2.5 |
| September 14th 2022 | Guggenheim | Initiation | Buy | $7 |
| August 15th 2022 | Jefferies | Initiation | Buy | $10 |
Earnings History & Surprises
TOIBeat Rate
17%
Last 12 quarters
Avg Surprise
-42.1%
EPS vs Estimate
Beats / Misses
2/9
1 met exactly
Latest EPS
$-0.14
Q4 2025
EPS Surprise History
Q1 24
-90.9%
$-0.21vs$-0.11
Q2 24
-83.3%
$-0.22vs$-0.12
Q3 24
-70.0%
$-0.17vs$-0.10
Q4 24
-157.1%
$-0.18vs$-0.07
Q1 25
-75.0%
$-0.14vs$-0.08
Q2 25
No data
Q3 25
0.0%
$-0.14vs$-0.14
Q4 25
-16.7%
$-0.14vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 23, 2026 | $-0.08 | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.12 | $-0.14 | -16.7% | ✗ MISS |
Q3 2025 | Aug 13, 2025 | $-0.14 | $-0.14 | 0.0% | = MET |
Q2 2025 | May 14, 2025 | — | $-0.17 | — | — |
Q1 2025 | Mar 24, 2025 | $-0.08 | $-0.14 | -75.0% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.07 | $-0.18 | -157.1% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $-0.10 | $-0.17 | -70.0% | ✗ MISS |
Q2 2024 | May 14, 2024 | $-0.12 | $-0.22 | -83.3% | ✗ MISS |
Q1 2024 | Mar 27, 2024 | $-0.11 | $-0.21 | -90.9% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.13 | $-0.19 | -46.2% | ✗ MISS |
Q3 2023 | Aug 8, 2023 | $-0.17 | $-0.19 | -11.8% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.17 | $-0.10 | +41.2% | ✓ BEAT |
Q1 2023 | Mar 9, 2023 | $-0.18 | $-0.16 | +11.1% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | $-0.16 | $-0.17 | -6.3% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | — | $-0.06 | — | — |
Q2 2022 | May 11, 2022 | — | $-0.29 | — | — |
Q1 2022 | Mar 10, 2022 | — | $0.26 | — | — |
Q4 2021 | Nov 8, 2021 | — | $-0.04 | — | — |
Q3 2021 | Aug 16, 2021 | — | $0.05 | — | — |
Q2 2021 | May 28, 2021 | — | $-0.02 | — | — |
Latest News
The Oncology Institute Projects 2026 Revenue to Hit $650M
📈 PositiveBenzinga•Jan 12, 2026, 01:07 PM
Watching The Oncology Institute; Hearing Zacks Under $10 Newsletter Picks Stock
➖ NeutralBenzinga•Jan 6, 2026, 03:59 PM
Needham Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $5
📈 PositiveBenzinga•Nov 25, 2025, 11:36 AM
The Oncology Institute shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Nov 14, 2025, 03:07 PM
The Oncology Institute shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Nov 13, 2025, 09:23 PM
Oncology Institute Raises FY2025 Sales Guidance from $460.000M-$480.000M to $495.000M-$505.000M vs $474.067M Est
📈 PositiveBenzinga•Nov 13, 2025, 09:09 PM
The Oncology Institute Q3 EPS $(0.14) Misses $(0.11) Estimate, Sales $136.564M Beat $122.633M Estimate
➖ NeutralBenzinga•Nov 13, 2025, 09:08 PM
Ascertain, Oncology Institute Collaborate To Co-Develop Administrative Workforce To Mitigate Manual Interactions Among Players, Providers
📈 PositiveBenzinga•Nov 13, 2025, 09:05 PM
The Oncology Institute Reports Cyber Incident At IT Vendor Causing Minor Delay In Fee-For-Service Collections; Says No Evidence Of Patient Data Compromise In Incident
➖ NeutralBenzinga•Nov 6, 2025, 11:21 PM
BTIG Reiterates Buy on Oncology Institute, Maintains $7 Price Target
📈 PositiveBenzinga•Oct 21, 2025, 10:57 AM
The Oncology Institute Reaches $1.1M In Medicare Savings In CMS Enhancing Oncology Model Performance Period 2 Through California Professional Corporation
📈 PositiveBenzinga•Sep 22, 2025, 12:07 PM
The Oncology Institute Q2 Revenue Surges
📈 PositiveThe Motley Fool•Aug 13, 2025, 10:00 PM
Frequently Asked Questions about TOI
What is TOI's current stock price?
The Oncology Institute, Inc. (TOI) is currently trading at $3.71 per share. The stock has moved -3.77% today.
What is the analyst price target for TOI?
The average analyst price target for TOI is $5.00, based on 1 analyst.
What sector is The Oncology Institute, Inc. in?
The Oncology Institute, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.
What is TOI's market cap?
The Oncology Institute, Inc. has a market capitalization of $0.36 billion, making it a small-cap company.
Does TOI pay dividends?
No, The Oncology Institute, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAGL
Agilon Health, Inc.
$0.96
Mkt Cap: $0.4B
AUNA
Auna S.A.
$4.72
Mkt Cap: $0.3B
AUTL
Autolus Therapeutics plc
$1.36
Mkt Cap: $0.4B
CBLL
CeriBell, Inc.
$22.90
Mkt Cap: $0.8B
CCRN
Cross Country Healthcare, Inc.
$8.42
Mkt Cap: $0.3B
EHAB
Enhabit, Inc.
$10.97
Mkt Cap: $0.6B
EOLS
Evolus, Inc.
$5.61
Mkt Cap: $0.4B
KIDS
OrthoPediatrics Corp.
$18.84
Mkt Cap: $0.5B
SNDA
Sonida Senior Living, Inc.
$31.86
Mkt Cap: $0.6B
TMCI
Treace Medical Concepts, Inc.
$2.77
Mkt Cap: $0.2B
Explore stocks similar to TOI for comparison